ClinicalTrials.gov record
Recruiting Phase 3 Interventional

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

ClinicalTrials.gov ID: NCT05848713

Public ClinicalTrials.gov record NCT05848713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05848713
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Manitoba
Other
Enrollment
4,000 participants

Conditions and interventions

Interventions

  • Heparin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 9, 2023
Primary completion
Mar 30, 2028
Completion
Mar 30, 2029
Last update posted
Apr 20, 2026

2023 – 2029

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
University of Chicago Chicago Illinois 60637 Not yet recruiting
Ochsner Clinic Jefferson Louisiana 70121 Recruiting
Maine Medical Centre Portland Maine 04102 Recruiting
Henry Ford Health System Dearborn Michigan 48128 Completed
Cooper University Health Care Camden New Jersey 08103 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05848713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05848713 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →